1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Plasma-derived Therapies Market Size Growth Rate by Type (2021-2027) 1.2.2 Albumin 1.2.3 Immunoglobulin 1.2.4 Factor VIII 1.2.5 Others 1.3 Market by Application 1.3.1 Global Plasma-derived Therapies Market Share by Application (2021-2027) 1.3.2 Hemophilia 1.3.3 Primary Immunodeficiencies (PIDs) 1.3.4 Idiopathic Thrombocytopenic Purpura (ITP) 1.3.5 COVID-19 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Plasma-derived Therapies Market Size 2.2 Plasma-derived Therapies Market Size by Regions 2.2.1 Plasma-derived Therapies Growth Rate by Regions (2021-2027) 2.2.2 Plasma-derived Therapies Market Share by Regions (2021-2027) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 Plasma-derived Therapies Revenue by Players (2020-2021) 3.2 Plasma-derived Therapies Key Players Headquaters and Area Served 3.3 Key Players Plasma-derived Therapies Product/Solution/Service 3.4 Date of Enter into Plasma-derived Therapies Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global Plasma-derived Therapies Market Size by Type (2021-2027) 4.2 Global Plasma-derived Therapies Market Size by Application (2021-2027) 5 North America 5.1 North America Plasma-derived Therapies Market Forecast (2021-2027) 5.2 Plasma-derived Therapies Key Players in North America 5.3 North America Plasma-derived Therapies Market Size by Type 5.4 North America Plasma-derived Therapies Market Size by Application 6.4.4 Canada 6 Europe 6.1 Europe Plasma-derived Therapies Market Forecast (2021-2027) 6.2 Plasma-derived Therapies Key Players in Europe 6.3 Europe Plasma-derived Therapies Market Size by Type 6.4 Europe Plasma-derived Therapies Market Size by Application 7 Japan 7.1 Japan Plasma-derived Therapies Market Forecast (2021-2027) 7.2 Plasma-derived Therapies Key Players in Europe 7.3 Japan Plasma-derived Therapies Market Size by Type 7.4 Japan Plasma-derived Therapies Market Size by Application 8 Rest of World 8.1 China 8.1.1 China Plasma-derived Therapies Market Analysis 8.1.2 Key Players in China 8.2 Southeast Asia 8.2.1 Southeast Asia Plasma-derived Therapies Market Analysis 8.2.2 Key Players in Southeast Asia 8.3 India 8.3.1 India Plasma-derived Therapies Market Analysis 8.3.2 Key Players in India 9 International Player Profiles 9.1 CSL Behring LLC 9.1.1 CSL Behring LLC Company Details 9.1.2 CSL Behring LLC Description and Business Overview 9.1.3 CSL Behring LLC Plasma-derived Therapies Introduction 9.1.4 CSL Behring LLC Revenue in Plasma-derived Therapies Business (2020-2021) 9.1.5 CSL Behring LLC Recent Development 9.2 Shire 9.2.1 Shire Company Details 9.2.2 Shire Description and Business Overview 9.2.3 Shire Plasma-derived Therapies Introduction 9.2.4 Shire Revenue in Plasma-derived Therapies Business (2020-2021) 9.2.5 Shire Recent Development 9.3 Bayer 9.3.1 Bayer Company Details 9.3.2 Bayer Description and Business Overview 9.3.3 Bayer Plasma-derived Therapies Introduction 9.3.4 Bayer Revenue in Plasma-derived Therapies Business (2020-2021) 9.3.5 Bayer Recent Development 9.4 Kedrion 9.4.1 Kedrion Company Details 9.4.2 Kedrion Description and Business Overview 9.4.3 Kedrion Plasma-derived Therapies Introduction 9.4.4 Kedrion Revenue in Plasma-derived Therapies Business (2020-2021) 9.4.5 Kedrion Recent Development 9.5 Takeda 9.5.1 Takeda Company Details 9.5.2 Takeda Description and Business Overview 9.5.3 Takeda Plasma-derived Therapies Introduction 9.5.4 Takeda Revenue in Plasma-derived Therapies Business (2020-2021) 9.5.5 Takeda Recent Development 9.6 Biotest 9.6.1 Biotest Company Details 9.6.2 Biotest Description and Business Overview 9.6.3 Biotest Plasma-derived Therapies Introduction 9.6.4 Biotest Revenue in Plasma-derived Therapies Business (2020-2021) 9.6.5 Biotest Recent Development 9.7 Octaparma 9.7.1 Octaparma Company Details 9.7.2 Octaparma Description and Business Overview 9.7.3 Octaparma Plasma-derived Therapies Introduction 9.7.4 Octaparma Revenue in Plasma-derived Therapies Business (2020-2021) 9.7.5 Octaparma Recent Development 9.8 Bio Products Laboratory (BPL) 9.8.1 Bio Products Laboratory (BPL) Company Details 9.8.2 Bio Products Laboratory (BPL) Description and Business Overview 9.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Introduction 9.8.4 Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2020-2021) 9.8.5 Bio Products Laboratory (BPL) Recent Development 9.9 LFB 9.9.1 LFB Company Details 9.9.2 LFB Description and Business Overview 9.9.3 LFB Plasma-derived Therapies Introduction 9.9.4 LFB Revenue in Plasma-derived Therapies Business (2020-2021) 9.9.5 LFB Recent Development 9.10 Grifols 9.10.1 Grifols Company Details 9.10.2 Grifols Description and Business Overview 9.10.3 Grifols Plasma-derived Therapies Introduction 9.10.4 Grifols Revenue in Plasma-derived Therapies Business (2020-2021) 9.10.5 Grifols Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details

List of Tables Table 1. Global Plasma-derived Therapies Market Size Growth Rate by Type (2021-2027) (US$ Million) Table 2. Key Players of Albumin Table 3. Key Players of Immunoglobulin Table 4. Key Players of Factor VIII Table 5. Key Players of Others Table 6. Global Plasma-derived Therapies Market Size Growth by Application (2021-2027) (US$ Million) Table 7. Global Plasma-derived Therapies Market Size by Regions (2021-2027) (US$ Million) Table 8. Global Plasma-derived Therapies Market Share by Regions (2021-2027) Table 9. Market Top Trends Table 10. Market Use Cases Table 11. Global Plasma-derived Therapies Revenue by Players (2020-2021) (US$ Million) Table 12. Global Plasma-derived Therapies Market Share by Players (2020-2021) Table 13. Key Players Headquarters and Area Served Table 14. Key Players Plasma-derived Therapies Product Solution and Service Table 15. Date of Enter into Plasma-derived Therapies Market Table 16. Mergers & Acquisitions, Expansion Plans Table 17. Global Plasma-derived Therapies Market Size by Type (2021-2027) (US$ Million) Table 18. Global Plasma-derived Therapies Market Size Share by Type (2021-2027) Table 19. Global Plasma-derived Therapies Market Size by Application (2021-2027) (US$ Million) Table 20. Global Plasma-derived Therapies Market Size Share by Application (2021-2027) Table 21. North America Key Players Plasma-derived Therapies Revenue (2020-2021) (US$ Million) Table 22. North America Key Players Plasma-derived Therapies Market Share (2020-2021) Table 23. North America Plasma-derived Therapies Market Size by Type (2021-2027) (US$ Million) Table 24. North America Plasma-derived Therapies Market Share by Type (2021-2027) Table 25. North America Plasma-derived Therapies Market Size by Application (2021-2027) (US$ Million) Table 26. North America Plasma-derived Therapies Market Share by Application (2021-2027) Table 27. Europe Key Players Plasma-derived Therapies Revenue (2020-2021) (US$ Million) Table 28. Europe Key Players Plasma-derived Therapies Market Share (2020-2021) Table 29. Europe Plasma-derived Therapies Market Size by Type (2021-2027) (US$ Million) Table 30. Europe Plasma-derived Therapies Market Share by Type (2021-2027) Table 31. Europe Plasma-derived Therapies Market Size by Application (2021-2027) (US$ Million) Table 32. Europe Plasma-derived Therapies Market Share by Application (2021-2027) Table 33. Japan Key Players Plasma-derived Therapies Revenue (2020-2021) (US$ Million) Table 34. Japan Key Players Plasma-derived Therapies Market Share (2020-2021) Table 35. Japan Plasma-derived Therapies Market Size by Type (2021-2027) (US$ Million) Table 36. Japan Plasma-derived Therapies Market Share by Type (2021-2027) Table 37. Japan Plasma-derived Therapies Market Size by Application (2021-2027) (US$ Million) Table 38. Japan Plasma-derived Therapies Market Share by Application (2021-2027) Table 39. Key Players in China Table 40. Key Players in Southeast Asia Table 41. Key Players in India Table 42. CSL Behring LLC Company Details Table 43. CSL Behring LLC Description and Business Overview Table 44. CSL Behring LLC Plasma-derived Therapies Product Table 45. CSL Behring LLC Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 46. CSL Behring LLC Recent Development Table 47. Shire Company Details Table 48. Shire Description and Business Overview Table 49. Shire Plasma-derived Therapies Product Table 50. Shire Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 51. Shire Recent Development Table 52. Bayer Company Details Table 53. Bayer Description and Business Overview Table 54. Bayer Plasma-derived Therapies Product Table 55. Bayer Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 56. Bayer Recent Development Table 57. Kedrion Company Details Table 58. Kedrion Description and Business Overview Table 59. Kedrion Plasma-derived Therapies Product Table 60. Kedrion Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 61. Kedrion Recent Development Table 62. Takeda Company Details Table 63. Takeda Description and Business Overview Table 64. Takeda Plasma-derived Therapies Product Table 65. Takeda Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 66. Takeda Recent Development Table 67. Biotest Company Details Table 68. Biotest Description and Business Overview Table 69. Biotest Plasma-derived Therapies Product Table 70. Biotest Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 71. Biotest Recent Development Table 72. Octaparma Company Details Table 73. Octaparma Description and Business Overview Table 74. Octaparma Plasma-derived Therapies Product Table 75. Octaparma Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 76. Octaparma Recent Development Table 77. Bio Products Laboratory (BPL) Company Details Table 78. Bio Products Laboratory (BPL) Description and Business Overview Table 79. Bio Products Laboratory (BPL) Plasma-derived Therapies Product Table 80. Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 81. Bio Products Laboratory (BPL) Recent Development Table 82. LFB Company Details Table 83. LFB Description and Business Overview Table 84. LFB Plasma-derived Therapies Product Table 85. LFB Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 86. LFB Recent Development Table 87. Grifols Company Details Table 88. Grifols Description and Business Overview Table 89. Grifols Plasma-derived Therapies Product Table 90. Grifols Revenue in Plasma-derived Therapies Business 2020 and 2021 Table 91. Grifols Recent Development Table 92. Plasma-derived Therapies Market Trends Table 93. Plasma-derived Therapies Market Drivers Table 94. Plasma-derived Therapies Market Challenges Table 95. Plasma-derived Therapies Market Restraints Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Global Plasma-derived Therapies Market Share by Type in 2021 & 2027 Figure 2. Albumin Features Figure 3. Immunoglobulin Features Figure 4. Factor VIII Features Figure 5. Others Features Figure 6. Global Plasma-derived Therapies Market Share by Application in 2021 & 2027 Figure 7. Hemophilia Case Studies Figure 8. Primary Immunodeficiencies (PIDs) Case Studies Figure 9. Idiopathic Thrombocytopenic Purpura (ITP) Case Studies Figure 10. COVID-19 Case Studies Figure 11. Others Case Studies Figure 12. Plasma-derived Therapies Report Years Considered Figure 13. Global Plasma-derived Therapies Market Size and Growth Rate (2020-2027) (US$ Million) Figure 14. Global Plasma-derived Therapies Market Share by Regions (2020-2027) Figure 15. Global Plasma-derived Therapies Market Share by Players in 2021 Figure 16. Global Plasma-derived Therapies Market Size Market Share by Type (2021-2027) Figure 17. Global Plasma-derived Therapies Market Size Market Share by Application (2021-2027) Figure 18. Global Plasma-derived Therapies Revenue Market Share by Application in 2021 Figure 19. North America Plasma-derived Therapies Market Size 2021-2027 (US$ Million) Figure 20. Europe Plasma-derived Therapies Market Size 2021-2027 (US$ Million) Figure 21. Japan Plasma-derived Therapies Market Size 2021-2027 (US$ Million) Figure 22. Plasma-derived Therapies Market Size in China (2021-2027) (US$ Million) Figure 23. Plasma-derived Therapies Market Size in Southeast Asia (2021-2027) (US$ Million) Figure 24. Plasma-derived Therapies Market Size in India (2021-2027) (US$ Million) Figure 25. Bottom-up and Top-down Approaches for This Report Figure 26. Data Triangulation Figure 27. Key Executives Interviewed

CSL Behring LLC Shire Bayer Kedrion Takeda Biotest Octaparma Bio Products Laboratory (BPL) LFB Grifols